Author:
Lotzová Eva,Savary C.A.,Totpal K.,Schachner J.,Lichtiger B.,McCredie K.B.,Freireich E.J
Subject
Cancer Research,Oncology,Hematology
Reference24 articles.
1. Observations on the systemic administration of autologous lymphokine activated killer cells and re combinant interleukin-2 to patients with metastatic cancer;Rosenberg;N. Engl. J. Med.,1985
2. Human lymphokine-activated killer cells: further isolation and characterization of the precursor and effector cell;Skibber;Nat. Immun. cell. Growth Regul.,1987
3. Most lymphokine activated killer (LAK) activity mediated by blood and splenic lymphocytes is attributable to stimulation of natural killer (NK) cells by interleukin-2;Herberman;Immun. Today,1987
4. Reassessment of LAK phenomenology—a review;Lotzová;Nat. Immun. Cell Growth Regul.,1987
5. Induction of NK cell activity against fresh human leukemia in culture with interleukin-2;Lotzová;J. Immun.,1987
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献